Literature DB >> 33845039

Particle engineering principles and technologies for pharmaceutical biologics.

Dongmei Cun1, Chengqian Zhang2, Hriday Bera1, Mingshi Yang3.   

Abstract

The global market of pharmaceutical biologics has expanded significantly during the last few decades. Currently, pharmaceutical biologic products constitute an indispensable part of the modern medicines. Most pharmaceutical biologic products are injections either in the forms of solutions or lyophilized powders because of their low oral bioavailability. There are certain pharmaceutical biologic entities formulated into particulate delivery systems for the administration via non-invasive routes or to achieve prolonged pharmaceutical actions to reduce the frequency of injections. It has been well documented that the design of nano- and microparticles via various particle engineering technologies could render pharmaceutical biologics with certain benefits including improved stability, enhanced intracellular uptake, prolonged pharmacological effect, enhanced bioavailability, reduced side effects, and improved patient compliance. Herein, we review the principles of the particle engineering technologies based on bottom-up approach and present the important formulation and process parameters that influence the critical quality attributes with some mathematical models. Subsequently, various nano- and microparticle engineering technologies used to formulate or process pharmaceutical biologic entities are reviewed. Lastly, an array of commercialized products of pharmaceutical biologics accomplished based on various particle engineering technologies are presented and the challenges in the development of particulate delivery systems for pharmaceutical biologics are discussed.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Microparticles; Nanoparticles; Particle engineering; Particulate delivery system; Pharmaceutical biologics

Mesh:

Substances:

Year:  2021        PMID: 33845039     DOI: 10.1016/j.addr.2021.04.006

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  5 in total

1.  Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa.

Authors:  Shihui Yu; Xiaohui Pu; Maizbha Uddin Ahmed; Heidi H Yu; Tarun Tejasvi Mutukuri; Jian Li; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2021-10-06       Impact factor: 5.875

2.  Effect of Buffer Salts on Physical Stability of Lyophilized and Spray-Dried Protein Formulations Containing Bovine Serum Albumin and Trehalose.

Authors:  Tarun Tejasvi Mutukuri; Jing Ling; Yong Du; Yongchao Su; Qi Tony Zhou
Journal:  Pharm Res       Date:  2022-06-28       Impact factor: 4.580

Review 3.  Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation.

Authors:  Andreea Crintea; Alina Gabriela Dutu; Alina Sovrea; Anne-Marie Constantin; Gabriel Samasca; Aurelian Lucian Masalar; Brigitta Ifju; Eugen Linga; Lidia Neamti; Rares Andrei Tranca; Zsolt Fekete; Ciprian Nicolae Silaghi; Alexandra Marioara Craciun
Journal:  Nanomaterials (Basel)       Date:  2022-04-17       Impact factor: 5.719

4.  Electrostatic spray drying for monoclonal antibody formulation.

Authors:  Tarun Tejasvi Mutukuri; Yuh-Fun Maa; Benson Gikanga; Robert Sakhnovsky; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2021-07-27       Impact factor: 6.510

Review 5.  Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release.

Authors:  Avelino Corma; Pablo Botella; Eva Rivero-Buceta
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.